Digital Medicine & Medtech Showcase
Registration for 2021 opens soon!
Articles & Video
REPORT: State of China Life Science - 2020 H1
Download this new exclusive ChinaBio® report with in-depth analysis of investment and partnering activity in China for 2020 H1 to discover the factors driving China life science investment. Learn how VC, IPO, and Partnering have rebounded despite COVID-19, but how M&A continues to slump.
China's Challenges and Opportunities in the Wake of COVID-19ChinaBio Partnering Forum 2020
Interview- Roche’s approach to drug discovery, innovation and meeting patients' needsLife Sciences
The biggest breakthroughs in life sciences the last 10 years
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPERDiversity
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
There are many ways for your organisation to engage a qualified audience of biopharma dealmakers, investors, and client prospects! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.
To find out more, contact Katharina Schropp, Portfolio Director:
firstname.lastname@example.org | +41 43 500 35 45
All opportunities can be customised to align with your needs and budget. Examples may include:
- Exhibition space
- Thought leadership opportunities
- High-impact branding and messaging
- Private/public hosted events (lunches, breakfasts, and receptions)
- Custom digital campaigns